Effect of combined treatment with insulin and metformin on 5′AMPactivated protein kinase activity in lymphocytes of diabetic patients

von Sokolova, L.K., Pushkarev, V.M., Belchina, Y.B., Pushkarev, V.V., Tronko, M.D.
Veröffentlicht 2018

Effect of combined treatment with insulin, metformin, and gliclazide on the expression and activity of Akt, mTOR, and p70S6K protein kinases in lymphocytes of diabetic patients

von Sokolova, L.K., Pushkarev, V.M., Belchina, Yu.B., Pushkarev, V.V., Vatseba, T.S., Tronko, M.D.
Veröffentlicht 2018

Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease

von Tronko, M.D., Cherviakova, S.A., Pushkarev, V.V., Belchina, Y.B., Kovzun, O.I., Pushkarev, V.M., Sokolova, L.K.
Veröffentlicht 2021

Apolipoprotein B and oxLDL levels in plasma of patients with diabetes, cardiovascular disease, and COVID-19

von Tronko, M.D., Cherviakova, S.A., Pushkarev, V.V., Belchina, Y.B., Kovzun, O.I., Pushkarev, V.M., Sokolova, L.K.
Veröffentlicht 2021

Effects of COVID-19, diabetes mellitus, and cardiovascular diseases on insulin receptor substrate-1 amount in the blood plasma of patients

von Tronko, M.D., Pushkarev, V.V., Sokolova, L.K., Cherviakova, S.A., Belchina, Yu.B., Kovzun, O.I., Pushkarev, V.M.
Veröffentlicht 2021

Effects of COVID-19 and diabetes mellitus on AMPKα1 and IRS-1 amount in the blood plasma of patients

von Tronko, M.D., Pushkarev, V.V., Sokolova, L.K., Cherviakova, S.A., Belchina, Y.B., Kovzun, O.I., Guda, B.B., Pushkarev, V.M.
Veröffentlicht 2022

NT-proBNP blood levels in patients with type 2 diabetes mellitus with anemia and after the dapagliflozin treatment

von Sokolova, L.K., Pushkarev, V.M., Belchina, Yu.B., Pushkarev, V.V., Furmanova, O.V., Cherviakova, S.A., Kovzun, O.I., Tronko, M.D.
Veröffentlicht 2018